Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mehmet Sıddık Dilek
Observed name:
Mehmet sıddık Dilek
Institution:
Dicle University
Observed institution:
Dicle University
ORCID:
0000-0001-7730-6946
Observed ORCID:
0000-0001-7730-6946
OpenAlex ID:
A5120405847
Regorafenib Treatment for Recurrent Glioblastoma Beyond Bevacizumab-Based Therapy: A Large, Multicenter, Real-Life Study
2024
·
Salih Tünbekici
, Haydar cagatay Yuksel
, et al.
·
Cancers
·
13
PDF
Real-world comparison of doxorubicin–ifosfamide versus gemcitabine–docetaxel regimens in metastatic uterine leiomyosarcoma: a multicenter retrospective study
2025
·
Salih Tunbekici
, Gokhan Sahin
, et al.
·
Discover Oncology
·
2
PDF
Efficacy and safety of doxorubicin–ifosfamide versus gemcitabine–docetaxel as first‐line therapy in advanced nonuterine leiomyosarcoma: A multicenter real‐world study
2025
·
Salih Tunbekici
, Gokhan Sahin
, et al.
·
International Journal of Cancer
·
1
Pretreatment prognostic nutritional index is associated with survival outcomes in locally advanced NSCLC treated with definitive chemoradiotherapy
2026
·
Serdar İleri
, Sezai Tunç
, et al.
·
Scientific Reports
PDF
Retrospective Analysis of 17p Deletion Status and Treatment Modalities in Patients with Chronic Lymphocytic Leukemia
2026
·
Mehmet Sıddık Dilek
, Abdullah Karakuş
, et al.
·
Acta haematologica oncologica Turcica.
PDF
Real-world effectiveness of total neoadjuvant therapy in locally advanced rectal cancer: a multicenter retrospective study
2026
·
Osman Sütcüoğlu
, Orhun Akdoğan
, et al.
·
Discover Oncology
Kanser Hastalarında Demir Eksikliği ve Yönetimi
2025
·
Mehmet Sıddık Dilek
, Zuhat Urakçı
·
Akademisyen Kitabevi eBooks
PDF
Demir ve İnsan Sağlığı Üzerine Etkileri
2025
·
Mehmet Sıddık Dilek
, Cihan Ural
, et al.
·
Akademisyen Kitabevi eBooks
PDF
Show more works
View as search
Works count:
8
Citation count:
16
H-index:
2
I10-index:
1
Year
Topic
Type
